Vascular center
Malmö, 23594, Sweden
NCT Number: NCT02750605
The purpose of this trial is to compare short- medium long-term results in treatment of PAD (peripheral arterial disease) in the crural arteries with either drug coated balloon or conventional balloons in a prospective , randomized, single center study
Results will be defined as:
Limb salvage, Event-free survival, Freedom from TLR (target lesion revascularization), Primary patency, Clinical success, Serious adverse events, and the patients will be followed-up for 1 years.
Primary endpoints:
Primary Patency at 12 months, TLR (clinical driven),
Secondary endpoints:
Event free survival, Clinical success at 6,12 months, Technical success, Serious adverse events,
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Malmö, 23594, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention with drug eluting balloon.
Intervention with old technology as comparison
Time frame: 12 months
Evaluation with MRA (Magnetic Resonans Angiography) at 12 months, regarding binary restenosis or occlusion in the treated arterial segment. Proportion of treated segments that remains open.
Time frame: 12 months
Porportion of patients that needs retreatment in in the monitored arterial segment
Skane University Hospital
Other
Randomized Trial Comparing Drug Coated Balloon vs Plain Balloon Angioplasty in Critical Limb Ischemia and Treatment of Long Lesions in Crural Arteries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394829
Cardiovascular Diseases, Peripheral Vascular Diseases
Ağrı, Merkez, Turkey (Türkiye)
View Trial DetailsNCT03404180
Arterial Occlusive Diseases, Arteriosclerosis
Gainesville, Florida, United States
View Trial DetailsNCT05459818
Cardiovascular Diseases, Peripheral Vascular Diseases
Arnhem, Netherlands
View Trial DetailsNCT04440839
Arterial Occlusive Diseases, Arteriosclerosis
Sacramento, California, United States
View Trial Details